This company has been marked as potentially delisted and may not be actively trading. Can B (CANB) Competitors Add Compare Share Share Competitors Stock AnalysisCompetitorsEarningsHeadlinesTrendsBuy This Stock CANB vs. COSM, HWH, MEDS, BIMI, MCK, COR, CAH, HLF, NUS, and CDIOShould you be buying Can B stock or one of its competitors? The main competitors of Can B include Cosmos Health (COSM), HWH International (HWH), TRxADE HEALTH (MEDS), BIMI (BIMI), McKesson (MCK), Cencora (COR), Cardinal Health (CAH), Herbalife (HLF), Nu Skin Enterprises (NUS), and Cardio Diagnostics (CDIO). Can B vs. Cosmos Health HWH International TRxADE HEALTH BIMI McKesson Cencora Cardinal Health Herbalife Nu Skin Enterprises Cardio Diagnostics Can B (NASDAQ:CANB) and Cosmos Health (NASDAQ:COSM) are both small-cap medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their earnings, dividends, valuation, profitability, risk, community ranking, analyst recommendations, media sentiment and institutional ownership. Is CANB or COSM more profitable? Cosmos Health has a net margin of -36.39% compared to Can B's net margin of -1,238.33%. Can B's return on equity of 0.00% beat Cosmos Health's return on equity.Company Net Margins Return on Equity Return on Assets Can B-1,238.33% N/A -218.65% Cosmos Health -36.39%-9.39%-5.10% Do insiders and institutionals hold more shares of CANB or COSM? 6.1% of Can B shares are owned by institutional investors. Comparatively, 12.6% of Cosmos Health shares are owned by institutional investors. 11.4% of Can B shares are owned by company insiders. Comparatively, 15.6% of Cosmos Health shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth. Does the media refer more to CANB or COSM? In the previous week, Cosmos Health had 6 more articles in the media than Can B. MarketBeat recorded 6 mentions for Cosmos Health and 0 mentions for Can B. Cosmos Health's average media sentiment score of 1.93 beat Can B's score of -0.14 indicating that Cosmos Health is being referred to more favorably in the news media. Company Overall Sentiment Can B Neutral Cosmos Health Very Positive Which has preferable valuation & earnings, CANB or COSM? Can B has higher earnings, but lower revenue than Cosmos Health. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioCan B$2.16M2.33-$9.74MN/AN/ACosmos Health$54.43M0.21-$18.54M-$1.16-0.36 Does the MarketBeat Community prefer CANB or COSM? Cosmos Health received 24 more outperform votes than Can B when rated by MarketBeat users. Likewise, 70.69% of users gave Cosmos Health an outperform vote while only 58.62% of users gave Can B an outperform vote. CompanyUnderperformOutperformCan BOutperform Votes1758.62% Underperform Votes1241.38% Cosmos HealthOutperform Votes4170.69% Underperform Votes1729.31% Which has more volatility & risk, CANB or COSM? Can B has a beta of 1.46, meaning that its stock price is 46% more volatile than the S&P 500. Comparatively, Cosmos Health has a beta of 5.5, meaning that its stock price is 450% more volatile than the S&P 500. SummaryCosmos Health beats Can B on 10 of the 13 factors compared between the two stocks. Get Can B News Delivered to You Automatically Sign up to receive the latest news and ratings for CANB and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart CANB vs. The Competition Export to ExcelMetricCan BDrugs, proprietaries, & sundries IndustryMedical SectorNASDAQ ExchangeMarket Cap$5.04M$22.59B$5.47B$7.82BDividend YieldN/A1.58%5.43%4.30%P/E RatioN/A12.5822.3518.43Price / Sales2.339.77391.12101.46Price / CashN/A12.9538.1834.62Price / Book-0.2232.686.684.19Net Income-$9.74M$785.39M$3.22B$248.05M Can B Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)CANBCan BN/A$0.06+7.5%N/A+60.0%$5.04M$2.16M0.0016Gap UpCOSMCosmos Health2.2949 of 5 stars$0.33+4.5%N/A-18.6%$7.72M$56.04M-0.14100Insider TradeShort Interest ↓Positive NewsHWHHWH InternationalN/A$1.06+3.3%N/A-85.5%$6.89M$1.25M0.00N/AShort Interest ↓Gap UpMEDSTRxADE HEALTHN/A$0.87-3.9%N/A-84.8%$1.22M$7.45M0.0050Gap DownBIMIBIMIN/A$0.00flatN/A-99.9%$2,000.00$12.63M0.00520MCKMcKesson4.4461 of 5 stars$690.75+1.2%$668.50-3.2%+28.6%$86.32B$344.58B31.5475,000Positive NewsCORCencora4.1979 of 5 stars$283.87+1.0%$284.55+0.2%+19.3%$54.93B$638.56M40.2942,000Upcoming EarningsInsider TradeNews CoveragePositive NewsCAHCardinal Health4.4788 of 5 stars$133.12+1.5%$140.86+5.8%+32.6%$32.06B$222.28B24.7646,500Upcoming EarningsShort Interest ↑Positive NewsHLFHerbalife4.3354 of 5 stars$6.63+2.3%$12.00+81.1%-25.1%$672.50M$4.99B2.6710,100Upcoming EarningsNews CoverageNUSNu Skin Enterprises3.7096 of 5 stars$5.45-2.2%$6.88+26.3%-53.0%$270.49M$1.73B-1.8413,400CDIOCardio Diagnostics2.106 of 5 stars$0.39+4.1%$2.00+419.5%-33.0%$20.23M$34,890.000.001 Related Companies and Tools Related Companies COSM Competitors HWH Competitors MEDS Competitors BIMI Competitors MCK Competitors COR Competitors CAH Competitors HLF Competitors NUS Competitors CDIO Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:CANB) was last updated on 4/26/2025 by MarketBeat.com Staff From Our PartnersJames Altucher: Do not invest in AI unless…I made millions during the crypto boom. Many “experts” are now saying… Artificial Intelligence opportuni...Paradigm Press | SponsoredSilicon Valley Gold RushA new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredTrump’s treachery Forget what the media tells you. Trump’s inner circle may be pushing a financial reset that mirrors moves from...Porter & Company | SponsoredTrump’s tariffs just split the AI market in twoTrump’s tariff just split the AI market – among others – in two. One group of AI companies—the ones relying...Traders Agency | SponsoredWarning: “DOGE Collapse” imminentElon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week...Altimetry | SponsoredTrump announcement boosts “next Bitcoin”President Trump just made his first big crypto move ... Announcing the creation of a national strategic re...Weiss Ratings | SponsoredHere’s How to Claim Your Stake in Elon’s Private Company, xAII predict this single breakthrough could make Elon the world’s first trillionaire — and mint more new milliona...Brownstone Research | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowThe July 23rd Crypto Trigger Could Mark the Beginning of Bitcoin’s Next Big Move Bitcoin’s early 2024 ETF r...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Can B Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share Can B With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy CANB Stock Free CANB Stock Alerts